News
LLY
1207.02
+7.03%
79.33
Healthcare stocks have become a haven for investors ditching tech
MarketWatch · 1h ago
Eli Lilly: Exceptional Pipeline, Less Attractive Entry Point (Rating Downgrade)
Seeking Alpha · 2h ago
Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed
Seeking Alpha · 3h ago
How Micron aims to break through the risk cycle that has spooked investors for decades
MarketWatch · 3h ago
Eli Lilly Expands Donanemab Alzheimer’s Trial Into China, Targeting Preclinical Patients
TipRanks · 3h ago
Eli Lilly Tests Annual Donanemab Dosing: What Ongoing Alzheimer’s Study NCT07602582 Means for Investors
TipRanks · 3h ago
Lilly Ends Early-Stage Prostate Cancer Combo Trial, Nudging Investor Focus Back to Core Oncology Assets
TipRanks · 3h ago
Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms
Seeking Alpha · 3h ago
Why Moderna Stock Is Soaring and Leading the S&P 500 Today
Barron‘s · 4h ago
Acadia rises as EU backs Rett syndrome therapy
Seeking Alpha · 4h ago
FDA commissioner contenders down to three - report
Seeking Alpha · 4h ago
Lilly's Jaypirca Moves Closer To EU Approval After Strong Phase 3 Data
NASDAQ · 5h ago
Here’s Why Eli Lilly Stock (LLY) Is Up 6% Today
TipRanks · 5h ago
Lilly, Incyte, CSL among winners of EU drug recommendations this week
Seeking Alpha · 5h ago
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Benzinga · 5h ago
Medicare GLP-1 Bridge: What to expect
Seeking Alpha · 5h ago
Early notable gainers among liquid option names on June 26th
TipRanks · 6h ago
Lilly's Jaypirca Receives Positive CHMP Opinion For EU Approval In Chronic Lymphocytic Leukemia
NASDAQ · 7h ago
Eli Lilly Gets European Regulator's Nod for Leukemia Drug Jaypirca
Dow Jones · 8h ago
Cabaletta Bio: The Market Sold The EULAR News, I'm Buying
Seeking Alpha · 8h ago
More
Webull provides a variety of real-time LLY stock news. You can receive the latest news about Lilly Eli & Co through multiple platforms. This information may help you make smarter investment decisions.
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, and market products in a single business segment called human pharmaceutical products. The Company manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.